Items Tagged ‘TTFields’

October 22nd, 2015

Optune Approved for Newly Diagnosed Glioblastoma Multiforme


The United States Food and Drug Administration has expanded the approval of the Optune device for the treatment of patients with newly diagnosed glioblastoma multiforme. Glioblastoma multiforme (GBM) is an extremely aggressive form of brain cancer. Average survival of patients with GBM is less than 15 months because the cancer tends to be resistant to […]

View full entry

Tags: Brain Cancer, gbm, General Brain Cancer, glioblastoma multiforme, News, Optune device, temozolomide, TTFields